Prevalence and risk factors of having antibodies to class I and II human leukocyte antigens in older haploidentical allograft candidates

Documenti analoghi

• Haploidentical allograft is superior to matched sibling donor allograft in eradicating pre-transplantation minimal residual disease of AML patients as determined by multiparameter flow cytometry: a retrospective and prospective analysis
  di: Chang, Ying-Jun, et al.
  Pubblicazione: (2017)
• Dynamic immune profiling identifies the stronger graft-versus-leukemia (GVL) effects with haploidentical allografts compared to HLA-matched stem cell transplantation
  di: Guo, Huidong, et al.
  Pubblicazione: (2021)
• Donor-specific anti-human leukocyte antigen antibodies were associated with primary graft failure after unmanipulated haploidentical blood and marrow transplantation: a prospective study with randomly assigned training and validation sets
  di: Chang, Ying-Jun, et al.
  Pubblicazione: (2015)
• Relationship of Cell Compositions in Allografts with Outcomes after Haploidentical Transplantation for Acquired Severe Aplastic Anemia: Effects of CD34(+) and CD14(+) Cell Doses
  di: Cao, Le-Qing, et al.
  Pubblicazione: (2018)
• Haploidentical donor is preferred over matched sibling donor for pre-transplantation MRD positive ALL: a phase 3 genetically randomized study
  di: Chang, Ying-Jun, et al.
  Pubblicazione: (2020)